https://www.indianpharmapost.com/sigachi-industries-posts-q2-fy2026-consolidated-profit-at-rs-1068-cr-180722025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/lilly-buys-adverum-for-its-phase-3-stage-eye-disease-gene-therapy-180812025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofis-q3-profit-dips-marginally-as-dupixent-sales-top-4-billion-180802025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsk-acquires-rights-to-prostate-cancer-candidate-from-syndivia-for-up-to-268-million-180792025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-to-acquire-avidity-biosciences-for-12-billion-180782025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/cphi-pmec-india-2025-to-see-participation-of-2000-exhibitors-180772025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/anrf-in-collaboration-with-icmr-and-gates-foundation-launches-maha-medtech-mission-180762025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/health-minister-nadda-addresses-50th-convocation-of-aiims-new-delhi-180752025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-laboratories-reports-q2-fy26-consolidated-pat-at-rs-14372-cr-180742025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-approval-from-health-canada-for-mesalamine-suppositories-180732025-10-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/telangana-targets-rs1-lakh-crore-investments-in-life-sciences-by-2030-180822025-10-27T00:00:00+05:30always0.9